Source: Frontiers in Immunology. Unidades: FCF, FM
Subjects: COLITE, DOENÇA DE CROHN, RECEPTORES, PEPTÍDEOS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Marina de Paula et al. Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease. Frontiers in Immunology, v. 12, p. 1-12 art. 714138, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2021.714138. Acesso em: 28 maio 2024.APA
Silva, M. de P., Rocha, G. H. O. da, Broering, M. F., Queiroz, M. L., Sandri, S., Loiola, R. A., et al. (2021). Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease. Frontiers in Immunology, 12, 1-12 art. 714138. doi:10.3389/fimmu.2021.714138NLM
Silva M de P, Rocha GHO da, Broering MF, Queiroz ML, Sandri S, Loiola RA, Oliani SM, Vieira A, Mauro Perretti, Farsky SHP. Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease [Internet]. Frontiers in Immunology. 2021 ; 12 1-12 art. 714138.[citado 2024 maio 28 ] Available from: https://doi.org/10.3389/fimmu.2021.714138Vancouver
Silva M de P, Rocha GHO da, Broering MF, Queiroz ML, Sandri S, Loiola RA, Oliani SM, Vieira A, Mauro Perretti, Farsky SHP. Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease [Internet]. Frontiers in Immunology. 2021 ; 12 1-12 art. 714138.[citado 2024 maio 28 ] Available from: https://doi.org/10.3389/fimmu.2021.714138